Search Results - "TACCHETTI, P"

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease by Zamagni, E, Nanni, C, Gay, F, Pezzi, A, Patriarca, F, Bellò, M, Rambaldi, I, Tacchetti, P, Hillengass, J, Gamberi, B, Pantani, L, Magarotto, V, Versari, A, Offidani, M, Zannetti, B, Carobolante, F, Balma, M, Musto, P, Rensi, M, Mancuso, K, Dimitrakopoulou-Strauss, A, Chauviè, S, Rocchi, S, Fard, N, Marzocchi, G, Storto, G, Ghedini, P, Palumbo, A, Fanti, S, Cavo, M

“…Identification of patient sub-groups with smoldering multiple myeloma (SMM) at high risk of progression to active disease (MM) is an important goal. 18F-FDG…”
Get full text

Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma by Martello, M., Poletti, A., Borsi, E., Solli, V., Dozza, L., Barbato, S., Zamagni, E., Tacchetti, P., Pantani, L., Mancuso, K., Vigliotta, I., Rizzello, I., Rocchi, S., Armuzzi, S., Testoni, N., Marzocchi, G., Martinelli, G., Cavo, M., Terragna, C.

“…Aberrations on TP53 , either as deletions of chromosome 17p (del17p) or mutations, are associated with poor outcome in multiple myeloma (MM), but conventional…”
Get full text

Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma by Cavo, M, Pantani, L, Pezzi, A, Petrucci, M T, Patriarca, F, Di Raimondo, F, Marzocchi, G, Galli, M, Montefusco, V, Zamagni, E, Gamberi, B, Tacchetti, P, Brioli, A, Palumbo, A, Sonneveld, P

Get full text

Neuropathy in multiple myeloma treated with thalidomide : A prospective study by PLASMATI, R, PASTORELLI, F, MICHELUCCI, R, TASSINARI, C. A, CAVO, M, PETRACCI, E, ZAMAGNI, E, TOSI, P, CANGINI, D, TACCHETTI, P, SALVI, F, BARTOLOMEI, I

“…Thalidomide is effective as a first-line therapy for the treatment of multiple myeloma (MM), but its use is limited by peripheral neurotoxicity. To study the…”
Get full text

Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138−CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis by Martello, M, Remondini, D, Borsi, E, Santacroce, B, Procacci, M, Pezzi, A, Dico, F A, Martinelli, G, Zamagni, E, Tacchetti, P, Pantani, L, Testoni, N, Marzocchi, G, Rocchi, S, Zannetti, B A, Mancuso, K, Cavo, M, Terragna, C

“…Hyperactivation of the Hedgehog (Hh) pathway, which controls refueling of multiple myeloma (MM) clones, might be critical to disease recurrence. Although…”
Get full text

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma by Zamagni, Elena, Nanni, Cristina, Patriarca, Francesca, Englaro, Emanuela, Castellucci, Paolo, Geatti, Onelio, Tosi, Patrizia, Tacchetti, Paola, Cangini, Delia, Perrone, Giulia, Ceccolini, Michela, Brioli, Annamaria, Buttignol, Silvia, Fanin, Renato, Salizzoni, Eugenio, Baccarani, Michele, Fanti, Stefano, Cavo, Michele

“…From the Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli", Università di Bologna, Italia (EZ, PTo, PTa, DC, GP, MC, AB, MB, MC); Istituto di…”
Get full text

The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma by Zamagni, E, Tacchetti, P, Deias, P, Patriarca, F

“…The recent introduction of monoclonal antibodies (MoAbs), with several cellular targets, such as CD-38 (daratumumab and isatuximab) and SLAM F7 (elotuzumab),…”
Get full text

Multiple myeloma: disease response assessment by Zamagni, E, Tacchetti, P, Terragna, C, Cavo, M

“…Precise assessment of response to therapy is of high importance in every phase of multiple myeloma (MM). In addition to the well-established role of monoclonal…”
Get more information

Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation by Brioli, A, Perrone, G, Patriarca, F, Pezzi, A, Nobile, F, Ballerini, F, Motta, M R, Ronconi, S, Tacchetti, P, Catalano, L, Zannetti, B A, Rizzi, S, Volpe, S, Zamagni, E, Liberati, A M, Mancuso, K, Boccadoro, M, Davies, F E, Morgan, G J, Palumbo, A, Cavo, M

“…Incorporation of novel agents into auto-SCT for patients with multiple myeloma has led to improvement in their outcomes. However, the effects of new drugs,…”
Get full text

Tele-Assistance in pediatric neuromuscular disorders requiring home mechanical ventilation, multicentric study by Trucco, F, Pedemonte, M, Racca, F, Falsaperla, R, Romano, C, Wenzel, A, Tacchetti, P, Bella, C, Bruno, C, Minetti, C

Get full text

Role of Consolidation Therapy in Transplant Eligible Multiple Myeloma Patients by Cavo, Michele, Brioli, Annamaria, Tacchetti, P, Zannetti, B.A, Mancuso, K, Zamagni, E

“…The role of high-dose therapy and autologous stem-cell transplantation (ASCT) in the treatment of multiple myeloma (MM) has continued to evolve in recent…”
Get full text

P893: CARFILZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (KRD) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS: ITALIAN, MULTICENTER, RETROSPECTIVE EXPERIENCE OUTSIDE OF CLINICAL TRIALS by Martino, E. A., Conticello, C., Zamagni, E., Pavone, V., Palmieri, S., Musso, M., Tacchetti, P., Mele, A., Catlano, L., Vigna, E., Bruzzese, A., Mendicino, F., Botta, C., Vincelli, D., Farina, G., Barone, M., Cangialosi, C., Mancuso, K., Rizziello, I., Rocchi, S., Falcone, A. P., Mele, G., Reddiconto, G., Garibaldi, B., Iaccino, E., Tripepi, G., Di Raimondo, F., Musto, P., Neri, A., Cavo, M., Morabito, F., Gentile, M.

Get full text

Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma by Pantani, L, Brioli, A, Tacchetti, P, Zannetti, B A, Mancuso, K, Rocchi, S, Martello, M, Rizzello, I, Terragna, C, Zamagni, E, Cavo, M

“…Despite significant improvement in outcomes have been observed for multiple myeloma (MM) patients over the past 10-15 years, mainly due to the introduction of…”
Get more information

Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma by Tosi, Patrizia, Zamagni, Elena, Cellini, Claudia, Plasmati, Rosaria, Cangini, Delia, Tacchetti, Paola, Perrone, Giulia, Pastorelli, Francesca, Tura, Sante, Baccarani, Michele, Cavo, Michele

“…: Objective: Thalidomide is remarkably active in advanced relapsed and refractory multiple myeloma (MM), so that its use has been recently proposed either in…”
Get full text

Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure by Tosi, Patrizia, Zamagni, Elena, Cellini, Claudia, Cangini, Delia, Tacchetti, Paola, Tura, Sante, Baccarani, Michele, Cavo, Michele

“…:  Salvage therapy of patients with advanced, relapsed and refractory multiple myeloma (MM) is often limited by poor marrow reserve and multi‐organ impairment…”
Get full text

Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease by Brioli, A, Zamagni, E, Pasquali, S, Tosi, P, Tacchetti, P, Perrone, G, Pantani, L, Petrucci, A, Zannetti, B A, Baccarani, M, Cavo, M

Get full text

Hedgehog Pathway Over Expression Identifies Myeloma Patients With Worse Prognosis by Martello, M, Remondini, D, Pezzi, A, Borsi, E, Procacci, M, Dico, A.F, Santacroce, B, Pantani, L, Zamagni, E, Tacchetti, P, Rocchi, S, Zannetti, B.A, Marzocchi, G, Testoni, N, Martinelli, G, Cavo, M, Terragna, C

Get full text

S174: HIGH LEVEL OF CIRCULATING TUMOUR DNA AT DIAGNOSIS CORRELATES WITH DISEASE SPREADING AND DEFINES MULTIPLE MYELOMA PATIENTS WITH POOR PROGNOSIS by Martello, M., Poletti, A., Bezzi, D., Borsi, E., Taurisano, B., Solli, V., Armuzzi, S., Vigliotta, I., Mazzocchetti, G., Pistis, I., Pantani, L., Rocchi, S., Mancuso, K., Tacchetti, P., Rizzello, I., Cavo, M., Zamagni, E., Nanni, C., Terragna, C.

Get full text

PO-03 bFGF, IL-6, TNF-α and VEGF serum levels in newly diagnosed multiple myeloma patients treated with thalidomide, dexamethasone and autologous transplantation by Cellini, C, Tazzari, V, Grafone, T, Conti, M, Baccini, C, Zamagni, E, Cangini, D, Tacchetti, P, Tosi, P, Zaccaria, A, Cavo, M

Get full text

P.208 - Tele-Assistance in pediatric neuromuscular disorders requiring home mechanical ventilation, multicentric study by Trucco, F., Pedemonte, M., Racca, F., Falsaperla, R., Romano, C., Wenzel, A., Tacchetti, P., Bella, C., Bruno, C., Minetti, C.

Get full text